West Pharmaceutical Services WST Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $542.7M+16.2% | $493.7M+0.2% | $491.7M-1.6% | $487.7M-7.1% | $467.2M-17.8% | ||
| $174.1M+11.5% | $168.6M+11.1% | $162M+10.5% | $159M+11.9% | $156.2M+13.4% | ||
| $29.1M+94.0% | $23.8M+27.3% | $21.4M+35.4% | $18.1M+9.0% | $15M-24.2% | ||
| $11.7M+67.1% | $11.7M+60.3% | $9.8M+113% | $10.5M+47.9% | $7M-15.7% | ||
| —— | -$6.9M-112% | $9.53M-77.9% | $25.95M-5.3% | $42.38M+262% | ||
| —— | $62.8M+250% | $36.6M+230% | $10.4M+173% | -$15.8M-4,113% | ||
| —— | $17.9M+517% | $14.15M+332% | $10.4M+185% | $6.65M+65.2% | ||
| -$112M-106% | -$108.1M-378% | -$27.9M+36.0% | -$23.3M+67.0% | -$54.3M-198% | ||
| —— | -$9.7M-267% | -$5.83M-160% | -$1.95M-114% | $1.93M-89.0% | ||
| —— | $10.5M-21.6% | $11.23M-17.6% | $11.95M-13.7% | $12.68M-9.9% | ||
| $715.3M+7.6% | $754.8M+15.5% | $693.8M-1.2% | $676.7M-10.1% | $664.6M-12.2% | ||
| $257.3M-28.1% | $285.9M-24.2% | $314.7M-17.4% | $332.7M-15.8% | $357.7M-3.5% | ||
| -$257.3M+28.4% | -$285.9M+24.5% | -$314.6M+17.8% | -$333.4M+15.9% | -$359.4M+4.7% | ||
| $61.8M+3.7% | $61.2M+3.6% | $60.7M+3.6% | $60.1M+3.4% | $59.6M+3.5% | ||
| —— | —— | —— | $240.8M-63.5% | $427.4M-33.8% | ||
| $14.3M+8.3% | $11.3M-55.7% | $9.7M-61.7% | $11.6M-70.9% | $13.2M-70.8% | ||
| $1.2M-94.9% | $1.1M-95.3% | $900K-96.2% | $900K-96.1% | $23.5M+11,650% | ||
| $2.8M0.0% | $2.8M-50.9% | $2.8M-50.0% | $2.7M-54.2% | $2.8M-58.8% | ||
| -$346.8M+30.4% | -$185.1M+70.3% | -$242.3M+67.4% | -$295.2M+57.9% | -$498.6M+24.4% | ||
| —— | —— | —— | $15.4M+402% | -$4.2M-5.0% | ||
| $117.2M— | $306.7M— | $137.6M— | —— | —— | ||
| —— | $300K-40.0% | $350K-81.3% | $400K-87.7% | $450K-90.3% | ||
| —— | $125.2M+75.4% | $111.75M+46.6% | $98.3M+21.2% | $84.85M-1.3% | ||
| $2.5M-30.6% | $2.8M-22.2% | $3.1M-22.5% | $3.3M-17.5% | $3.6M0.0% | ||
| $11.7M+67.1% | $11.7M+60.3% | $9.8M+113% | $10.5M+47.9% | $7M-15.7% | ||
| $174.1M+11.5% | $168.6M+11.1% | $162M+10.5% | $159M+11.9% | $156.2M+13.4% | ||
| —— | $10.5M-21.6% | $11.23M-17.6% | $11.95M-13.7% | $12.68M-9.9% | ||
| —— | —— | —— | —— | —— | ||
| —— | -$9.7M-267% | -$5.83M-160% | -$1.95M-114% | $1.93M-89.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | $600K+130% | -$50K+97.7% | -$700K+69.6% | -$1.35M+44.9% | ||
| $1.2M-94.9% | $1.1M-95.3% | $900K-96.2% | $900K-96.1% | $23.5M+11,650% | ||
| $7M-1.4% | $6.9M-4.2% | $7M-5.4% | $7.1M-2.7% | $7.1M-2.7% | ||
| —— | —— | $2.5M— | $1.6M— | $800K— | ||
| —— | $125.2M+75.4% | $111.75M+46.6% | $98.3M+21.2% | $84.85M-1.3% | ||
| $458M+49.2% | $468.9M+69.6% | $379.1M+17.9% | $344M-3.7% | $306.9M-20.5% | ||
| $458M+49.2% | $468.9M+69.6% | $379.1M+17.9% | $344M-3.7% | $306.9M-20.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does West Pharmaceutical Services generate?
- West Pharmaceutical Services (WST) generated $715.3M in operating cash flow over the trailing twelve months.
- What is West Pharmaceutical Services's free cash flow?
- After $257.3M of capital expenditures, West Pharmaceutical Services's free cash flow was $458.0M over the trailing twelve months, up 49.2% year over year.
- Where does West Pharmaceutical Services's cash flow data come from?
- Every line is extracted from West Pharmaceutical Services's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
